Northwire Canada EditionSaturday, July 18, 2026
Northwire
AII 19.25 +3.9% GGA 5.95 +12.3% VM 0.140 +3.7% GSR 0.365 +1.4% QCX 0.195 +0.0% EAU 0.085 +0.0% MCM 0.310 +0.0% BAT 0.100 +5.3% SFR 0.370 +68.2% FFU 0.125 +4.2% TVI 0.045 −10.0% ZNX 0.080 +0.0% TSK 1.06 +0.9% OMM 0.050 +0.0% EMO 0.320 −7.2% MDM 0.060 +0.0% AII 19.25 +3.9% GGA 5.95 +12.3% VM 0.140 +3.7% GSR 0.365 +1.4% QCX 0.195 +0.0% EAU 0.085 +0.0% MCM 0.310 +0.0% BAT 0.100 +5.3% SFR 0.370 +68.2% FFU 0.125 +4.2% TVI 0.045 −10.0% ZNX 0.080 +0.0% TSK 1.06 +0.9% OMM 0.050 +0.0% EMO 0.320 −7.2% MDM 0.060 +0.0%

← Back to our analysis

Original News Release

Unidoc Health amends LIFE offering

Mr. Antonio Baldassarre reports UNIDOC ANNOUNCES AMENDED LIFE OFFERING Unidoc Health Corp., further to its previously announced non-brokered private placement LIFE (listed issuer financing exemption) offering for total gross proceeds of up to $1.5-million, consisting of up to 10 million units of the company at a price of 15 cents per unit, has amended the terms of the offering to include a minimum offering amount. The offering will now consist of a minimum of 5,333,333 units for minimum gross proceeds of $800,000 and up to a maximum of 10 million units for gross proceeds of up to $1.5-million. Each unit will consist of one common share in the capital of the company and one transferable common share purchase warrant. Each warrant will entitle the holder to acquire an additional common share at a price of 25 cents for a period of 36 months following the closing of the offering. As previously disclosed, the company plans to use the proceeds from the offering for inventory, marketing and investor relations services, working capital, and general corporate purposes. The units will be offered by way of the listed issuer financing exemption under Part 5A of National Instrument 45-106, Prospectus Exemptions, in all of the provinces and territories of Canada, excluding Quebec. Pursuant to NI 45-106, the securities forming part of the units issued to Canadian resident subscribers under the offering will not be subject to resale restrictions. An amended and restated offering document related to the offering will be made available under the company's profile on SEDAR+. The amended offering document will also be made available on the issuer's website. Prospective investors of the units should read the amended offering document before making an investment decision. The offering is expected to close on or about Oct. 22, 2025, or such other date that is within 45 days from Oct. 17, 2025, as the company may agree. The offering remains subject to certain conditions customary for transactions of this nature, including, but not limited to, the receipt of all necessary approvals, including the approval of the Canadian Securities Exchange. About Unidoc Health Corp. Unidoc is developing an e-health solution that is being designed as a self-contained remote virtual clinic within a private kiosk for patients to undergo full consultations as if they were present in a physician's office. e-health opens the doors to a large segment of the population challenged by access, experience or understanding of on-line computer technology. It is the company's belief that physical accessibility is the key to its business proposition. Unidoc is dedicated to unlocking shareholder value by delivering an excellent product and sophisticated commercial network within an expedited time frame. We seek Safe Harbor.
View at source ↗